Patient-reported satisfaction and study drug discontinuation: post-hoc analysis of findings from ROCKET AF

Introduction: Patient-reported outcomes (PROs) and satisfaction endpoints are increasingly important in clinical trials and may be associated with treatment adherence. In this post hoc substudy from ROCKET AF, we examined whether patient-reported satisfaction was associated with study drug discontin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ungar, Leo (VerfasserIn) , Rodriguez, Fatima (VerfasserIn) , Hellkamp, Anne S. (VerfasserIn) , Becker, Richard C. (VerfasserIn) , Berkowitz, Scott D. (VerfasserIn) , Breithardt, Guenter (VerfasserIn) , Fox, Keith A. A. (VerfasserIn) , Hacke, Werner (VerfasserIn) , Halperin, Jonathan L. (VerfasserIn) , Hankey, Graeme J. (VerfasserIn) , Nessel, Christopher C. (VerfasserIn) , Singer, Daniel E. (VerfasserIn) , Patel, Manesh R. (VerfasserIn) , Piccini, Jonathan P. (VerfasserIn) , Mahaffey, Kenneth W. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2, 2019
In: Cardiology and therapy
Year: 2019, Jahrgang: 8, Heft: 2, Pages: 283-295
ISSN:2193-6544
DOI:10.1007/s40119-019-00146-6
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40119-019-00146-6
Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828909/
Volltext
Verfasserangaben:Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey

MARC

LEADER 00000caa a2200000 c 4500
001 1695796055
003 DE-627
005 20240405193243.0
007 cr uuu---uuuuu
008 200423s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s40119-019-00146-6  |2 doi 
035 |a (DE-627)1695796055 
035 |a (DE-599)KXP1695796055 
035 |a (OCoLC)1341316484 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ungar, Leo  |e VerfasserIn  |0 (DE-588)1197749314  |0 (DE-627)1679476939  |4 aut 
245 1 0 |a Patient-reported satisfaction and study drug discontinuation  |b post-hoc analysis of findings from ROCKET AF  |c Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey 
264 1 |c August 2, 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.04.2020 
520 |a Introduction: Patient-reported outcomes (PROs) and satisfaction endpoints are increasingly important in clinical trials and may be associated with treatment adherence. In this post hoc substudy from ROCKET AF, we examined whether patient-reported satisfaction was associated with study drug discontinuation. Methods: ROCKET AF (n = 14,264) compared rivaroxaban with warfarin for prevention of stroke and systemic embolism in patients with atrial fibrillation. We analyzed treatment satisfaction scores: the Anti-Clot Treatment Scale (ACTS) and Treatment Satisfaction Questionnaire for Medication version II (TSQM II). We compared satisfaction with study drug between the two treatment arms, and examined the association between satisfaction and patient-driven study drug discontinuation (stopping study drug due to withdrawal of consent, noncompliance, or loss to follow-up). Results: A total of 1577 (11%) patients participated in the Patient Satisfaction substudy; 1181 (8.3%) completed both the ACTS and TSQM II 4 weeks after starting study drug. Patients receiving rivaroxaban did not experience significant differences in satisfaction compared with those receiving warfarin. During a median follow-up of 1.6 years, 448 premature study drug discontinuations occurred (213 rivaroxaban group; 235 warfarin group), of which 116 (26%) were patient-driven (52 [24%] rivaroxaban group; 64 [27%] warfarin group). No significant differences were observed between satisfaction level and rates of patient-driven study drug discontinuation. Conclusions: Study drug satisfaction did not predict rate of study drug discontinuation. No significant difference was observed between satisfaction with warfarin and rivaroxaban, as expected given the double-blind trial design. Although these results are negative, the importance of PRO data will only increase, and these analyses may inform future studies that explore the relationship between drug-satisfaction PROs, adherence, and clinical outcomes. ClinicalTrials.gov - NCT00403767. Funding: The ROCKET AF trial was funded by Johnson & Johnson and Bayer. Electronic supplementary material - The online version of this article (10.1007/s40119-019-00146-6) contains supplementary material, which is available to authorized users. 
700 1 |a Rodriguez, Fatima  |e VerfasserIn  |4 aut 
700 1 |a Hellkamp, Anne S.  |e VerfasserIn  |4 aut 
700 1 |a Becker, Richard C.  |e VerfasserIn  |4 aut 
700 1 |a Berkowitz, Scott D.  |e VerfasserIn  |4 aut 
700 1 |a Breithardt, Guenter  |e VerfasserIn  |4 aut 
700 1 |a Fox, Keith A. A.  |e VerfasserIn  |4 aut 
700 1 |a Hacke, Werner  |d 1948-  |e VerfasserIn  |0 (DE-588)12021699X  |0 (DE-627)080530346  |0 (DE-576)164358854  |4 aut 
700 1 |a Halperin, Jonathan L.  |e VerfasserIn  |4 aut 
700 1 |a Hankey, Graeme J.  |e VerfasserIn  |4 aut 
700 1 |a Nessel, Christopher C.  |e VerfasserIn  |4 aut 
700 1 |a Singer, Daniel E.  |e VerfasserIn  |4 aut 
700 1 |a Patel, Manesh R.  |e VerfasserIn  |4 aut 
700 1 |a Piccini, Jonathan P.  |e VerfasserIn  |4 aut 
700 1 |a Mahaffey, Kenneth W.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cardiology and therapy  |d Heidelberg : Springer, 2012  |g 8(2019), 2, Seite 283-295  |h Online-Ressource  |w (DE-627)735684537  |w (DE-600)2700626-8  |w (DE-576)378488775  |x 2193-6544  |7 nnas  |a Patient-reported satisfaction and study drug discontinuation post-hoc analysis of findings from ROCKET AF 
773 1 8 |g volume:8  |g year:2019  |g number:2  |g pages:283-295  |g extent:13  |a Patient-reported satisfaction and study drug discontinuation post-hoc analysis of findings from ROCKET AF 
856 4 0 |u https://doi.org/10.1007/s40119-019-00146-6  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6828909/  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200423 
993 |a Article 
994 |a 2019 
998 |g 12021699X  |a Hacke, Werner  |m 12021699X:Hacke, Werner  |d 50000  |e 50000PH12021699X  |k 0/50000/  |p 8 
999 |a KXP-PPN1695796055  |e 3631269706 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"August 2, 2019"}],"relHost":[{"recId":"735684537","origin":[{"publisher":"Springer","dateIssuedDisp":"2012-","dateIssuedKey":"2012","publisherPlace":"Heidelberg"}],"disp":"Patient-reported satisfaction and study drug discontinuation post-hoc analysis of findings from ROCKET AFCardiology and therapy","pubHistory":["1.2012 -"],"language":["eng"],"id":{"zdb":["2700626-8"],"issn":["2193-6544"],"eki":["735684537"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 25.05.2020"],"part":{"issue":"2","extent":"13","text":"8(2019), 2, Seite 283-295","year":"2019","pages":"283-295","volume":"8"},"title":[{"title_sort":"Cardiology and therapy","title":"Cardiology and therapy"}]}],"name":{"displayForm":["Leo Ungar, Fatima Rodriguez, Anne S. Hellkamp, Richard C. Becker, Scott D. Berkowitz, Guenter Breithardt, Keith A.A. Fox, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Manesh R. Patel, Jonathan P. Piccini, Kenneth W. Mahaffey"]},"recId":"1695796055","physDesc":[{"extent":"13 S."}],"language":["eng"],"id":{"eki":["1695796055"],"doi":["10.1007/s40119-019-00146-6"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Patient-reported satisfaction and study drug discontinuation","subtitle":"post-hoc analysis of findings from ROCKET AF","title_sort":"Patient-reported satisfaction and study drug discontinuation"}],"person":[{"given":"Leo","role":"aut","family":"Ungar","display":"Ungar, Leo","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Fatima","display":"Rodriguez, Fatima","family":"Rodriguez","roleDisplay":"VerfasserIn"},{"given":"Anne S.","role":"aut","roleDisplay":"VerfasserIn","family":"Hellkamp","display":"Hellkamp, Anne S."},{"display":"Becker, Richard C.","family":"Becker","roleDisplay":"VerfasserIn","role":"aut","given":"Richard C."},{"given":"Scott D.","role":"aut","roleDisplay":"VerfasserIn","display":"Berkowitz, Scott D.","family":"Berkowitz"},{"roleDisplay":"VerfasserIn","display":"Breithardt, Guenter","family":"Breithardt","given":"Guenter","role":"aut"},{"display":"Fox, Keith A. A.","family":"Fox","roleDisplay":"VerfasserIn","role":"aut","given":"Keith A. A."},{"roleDisplay":"VerfasserIn","family":"Hacke","display":"Hacke, Werner","role":"aut","given":"Werner"},{"family":"Halperin","display":"Halperin, Jonathan L.","roleDisplay":"VerfasserIn","given":"Jonathan L.","role":"aut"},{"display":"Hankey, Graeme J.","family":"Hankey","roleDisplay":"VerfasserIn","role":"aut","given":"Graeme J."},{"family":"Nessel","display":"Nessel, Christopher C.","roleDisplay":"VerfasserIn","given":"Christopher C.","role":"aut"},{"given":"Daniel E.","role":"aut","family":"Singer","display":"Singer, Daniel E.","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Manesh R.","family":"Patel","display":"Patel, Manesh R.","roleDisplay":"VerfasserIn"},{"given":"Jonathan P.","role":"aut","roleDisplay":"VerfasserIn","display":"Piccini, Jonathan P.","family":"Piccini"},{"role":"aut","given":"Kenneth W.","roleDisplay":"VerfasserIn","family":"Mahaffey","display":"Mahaffey, Kenneth W."}],"note":["Gesehen am 23.04.2020"]} 
SRT |a UNGARLEOROPATIENTREP2201